Cargando…

Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model

BACKGROUND: Previous studies have reported that cancer stem cells (CSCs) play a key role in tumorigenesis, metastasis, and recurrence. CSC‐based vaccination confers better protection in tumor cells. However, isolation and cultivation of CSCs are difficult. This study aimed to explore the similaritie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingbo, Shao, Lijuan, Wu, Liujing, Ma, Wei, Zheng, Yuanyuan, Hu, Chaofeng, Li, Furong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262930/
https://www.ncbi.nlm.nih.gov/pubmed/32314522
http://dx.doi.org/10.1111/1759-7714.13440
_version_ 1783540717887422464
author Wang, Jingbo
Shao, Lijuan
Wu, Liujing
Ma, Wei
Zheng, Yuanyuan
Hu, Chaofeng
Li, Furong
author_facet Wang, Jingbo
Shao, Lijuan
Wu, Liujing
Ma, Wei
Zheng, Yuanyuan
Hu, Chaofeng
Li, Furong
author_sort Wang, Jingbo
collection PubMed
description BACKGROUND: Previous studies have reported that cancer stem cells (CSCs) play a key role in tumorigenesis, metastasis, and recurrence. CSC‐based vaccination confers better protection in tumor cells. However, isolation and cultivation of CSCs are difficult. This study aimed to explore the similarities between CSCs and induced pluripotent stem cells (iPSCs). METHODS: ALDH1+ cancer stem cells were isolated from lung adenocarcinoma patients and their gene expression patterns compared with human induced pluripotent stem cells (hiPSCs). In addition, a tumor vaccine was developed using hiPSC and unmethylated cytosine‐guanine (CpG). Finally, the antitumor properties of the vaccine were evaluated in a humanized mouse model. RESULTS: Preimmunization of iPSC+CpG elicited stronger antigen presentation and cytotoxic T cell response which suppressed the growth of tumors. Adoptive transfer of spleen T cells from the vaccine preimmunized mice inhibited tumor growth in unvaccinated recipients without any side effects. CONCLUSIONS: This study suggests a universal strategy for tumor therapy which simplifies future clinical procedures. Therefore, the application of hiPSC elicits tumor protective responses.
format Online
Article
Text
id pubmed-7262930
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-72629302020-06-03 Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model Wang, Jingbo Shao, Lijuan Wu, Liujing Ma, Wei Zheng, Yuanyuan Hu, Chaofeng Li, Furong Thorac Cancer Original Articles BACKGROUND: Previous studies have reported that cancer stem cells (CSCs) play a key role in tumorigenesis, metastasis, and recurrence. CSC‐based vaccination confers better protection in tumor cells. However, isolation and cultivation of CSCs are difficult. This study aimed to explore the similarities between CSCs and induced pluripotent stem cells (iPSCs). METHODS: ALDH1+ cancer stem cells were isolated from lung adenocarcinoma patients and their gene expression patterns compared with human induced pluripotent stem cells (hiPSCs). In addition, a tumor vaccine was developed using hiPSC and unmethylated cytosine‐guanine (CpG). Finally, the antitumor properties of the vaccine were evaluated in a humanized mouse model. RESULTS: Preimmunization of iPSC+CpG elicited stronger antigen presentation and cytotoxic T cell response which suppressed the growth of tumors. Adoptive transfer of spleen T cells from the vaccine preimmunized mice inhibited tumor growth in unvaccinated recipients without any side effects. CONCLUSIONS: This study suggests a universal strategy for tumor therapy which simplifies future clinical procedures. Therefore, the application of hiPSC elicits tumor protective responses. John Wiley & Sons Australia, Ltd 2020-04-20 2020-06 /pmc/articles/PMC7262930/ /pubmed/32314522 http://dx.doi.org/10.1111/1759-7714.13440 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Wang, Jingbo
Shao, Lijuan
Wu, Liujing
Ma, Wei
Zheng, Yuanyuan
Hu, Chaofeng
Li, Furong
Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
title Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
title_full Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
title_fullStr Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
title_full_unstemmed Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
title_short Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
title_sort expression levels of a gene signature in hipsc associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune‐response in a humanized mice model
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262930/
https://www.ncbi.nlm.nih.gov/pubmed/32314522
http://dx.doi.org/10.1111/1759-7714.13440
work_keys_str_mv AT wangjingbo expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel
AT shaolijuan expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel
AT wuliujing expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel
AT mawei expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel
AT zhengyuanyuan expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel
AT huchaofeng expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel
AT lifurong expressionlevelsofagenesignatureinhipscassociatedwithlungadenocarcinomastemcellsanditscapabilityinelicitingspecificantitumorimmuneresponseinahumanizedmicemodel